Stryker

YTD

ALL

Trade Stryker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments.

CEO

Kevin A. Lobo

CEOKevin A. Lobo

Employees

56,000

Employees56,000

Headquarters

Portage, Michigan

HeadquartersPortage, Michigan

Founded

1941

Founded1941

Employees

56,000

Employees56,000

SYK Key Statistics

Market cap

127.18B

Market cap127.18B

Price-Earnings ratio

39.57

Price-Earnings ratio39.57

Dividend yield

1.04%

Dividend yield1.04%

Average volume

1.97M

Average volume1.97M

High today

$333.08

High today$333.08

Low today

$327.70

Low today$327.70

Open price

$330.00

Open price$330.00

Volume

881.33K

Volume881.33K

52 Week high

$404.87

52 Week high$404.87

52 Week low

$319.32

52 Week low$319.32

Stock Snapshot

As of today, Stryker(SYK) shares are valued at $332.34. The company's market cap stands at 127.18B, with a P/E ratio of 39.57 and a dividend yield of 1.0%.

During the trading session on 2026-04-07, Stryker(SYK) shares reached a daily high of $333.08 and a low of $327.70. At a current price of $332.34, the stock is +1.4% higher than the low and still -0.2% under the high.

Trading activity shows a volume of 881.33K, compared to an average daily volume of 1.97M.

The stock's 52-week range extends from a low of $319.32 to a high of $404.87.

SYK News

TipRanks 7h

Citi cuts Stryker target, opens ‘downside 90-day catalyst watch’

Citi lowered the firm’s price target on Stryker (SYK) to $385 from $420 and keeps a Buy rating on the shares. Citi also added a “downside 90-day catalyst watch”...

Simply Wall St 17h

If You Believe In AI Healthcare Then These Three Stocks Could Shape Your Next Cycle

AI is starting to reshape how healthcare is delivered, from spotting disease earlier to tailoring treatments and cutting wasted time in hospitals, just as energ...

Simply Wall St 4d

Does Stryker’s Cyberattack Recovery Reveal Hidden Strengths in Its Long-Term Thesis?

In March 2026, Stryker reported a cyberattack that temporarily disrupted custom implant operations but, by late March, restored its electronic ordering system a...

Analyst ratings

81%

of 31 ratings

Buy

80.6%

Hold

19.4%

Sell

More SYK News

Nasdaq 4d

Here's Why Stryker is a Strong Growth Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Z...

People also own

Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.